Results 111 to 120 of about 9,019 (158)

Telmisartan

Drugs in R & D, 2002
openaire   +2 more sources

Advancing Drug Repurposing for Rheumatoid Arthritis: Integrating Protein-Protein Interaction, Molecular Docking, and Dynamics Simulations for Targeted Therapeutic Approaches. [PDF]

Curr Issues Mol Biol
Akey KS, Sanapalli BKR, Sigalapalli DK, Tokala R, Sanapalli V.   +4 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Amlodipine, Telmisartan, and Chlorthalidone in Newly Diagnosed Hypertensive Indian Adults. [PDF]

Cureus
Anwar MD, Verma V, Gulati S.
europepmc   +1 more source

The application of telmisartan in central nervous system disorders. [PDF]

Pharmacol Rep
Quan W, Zhang SX, Zhang XY, Chen X, Yang C, Li ZY, Hu R.   +6 more
europepmc   +1 more source

Treatment of non-small cell lung cancer using chem-bioinformatics-driven engineering of exosomal cargo-vehicle for telmisartan and pioglitazone targeted-delivery. [PDF]

Sci Rep
Hamdy NM, Sanad EF, Kassab SE, Essam M, Guirguis MA, Basalious EB, Sultan AS.   +6 more
europepmc   +1 more source

Endovascular Repair of Type IA Endoleak With Zone 0 TBE and Carotid-Carotid-Subclavian Bypass. [PDF]

JACC Case Rep
Multani AK, Vargo PR, Alexandrino FB, Caputo FJ, Wassif HS.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Telmisartan

Drugs, 2012
Karen J Mcclellan, K J Mcclellan, Markham Anthony   +2 more
exaly   +3 more sources

Telmisartan

Reactions Weekly, 2015
Telmisartan is an angiotensin-II receptor antagonist (ARB) used in the treatment of hypertension. Generally, angiotensin-II receptor blockers such as telmisartan bind to the angiotensin-II type 1 receptors with high affinity, causing inhibition of the action of angiotensin II on vascular smooth muscle, ultimately leading to a reduction in arterial ...
Ahmed H H, Bakheit, Ahmed A, Abd-Elgalil, Bakheit, Mustafa, Anzarul, Haque, Tanveer A, Wani   +4 more
  +7 more sources